Scribd Logo
Upload

Welcome to Scribd!

  • 189 views

    Drug Study Tetanus Toxoid

    Uploaded by

    Abdelmar Susulan
    After completing an initial immunization series, a booster dose of 0.5mL of tetanus toxoid should be given intramuscularly every 10 years to maintain immunity. Common side effects include redness, warmth, swelling and tenderness at the injection site, as well as general malaise, fever, pain, low blood pressure, nausea and joint pain. Special care must be taken when administering the injection to avoid entering a blood vessel. Tetanus toxoid is safe for breastfeeding mothers and their infants and does not affect immune response or breastfeeding. Its safety and effectiveness in infants under 6 weeks has not been established.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd

    Drug Study Tetanus Toxoid

    Uploaded by

    Abdelmar Susulan
    189 views1 page
    After completing an initial immunization series, a booster dose of 0.5mL of tetanus toxoid should be given intramuscularly every 10 years to maintain immunity. Common side effects include redness, warmth, swelling and tenderness at the injection site, as well as general malaise, fever, pain, low blood pressure, nausea and joint pain. Special care must be taken when administering the injection to avoid entering a blood vessel. Tetanus toxoid is safe for breastfeeding mothers and their infants and does not affect immune response or breastfeeding. Its safety and effectiveness in infants under 6 weeks has not been established.

    Original Title

    68445505 Drug Study Tetanus Toxoid

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    After completing an initial immunization series, a booster dose of 0.5mL of tetanus toxoid should be given intramuscularly every 10 years to maintain immunity. Common side effects include redness, warmth, swelling and tenderness at the injection site, as well as general malaise, fever, pain, low blood pressure, nausea and joint pain. Special care must be taken when administering the injection to avoid entering a blood vessel. Tetanus toxoid is safe for breastfeeding mothers and their infants and does not affect immune response or breastfeeding. Its safety and effectiveness in infants under 6 weeks has not been established.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    189 views1 page

    Drug Study Tetanus Toxoid

    Uploaded by

    Abdelmar Susulan
    After completing an initial immunization series, a booster dose of 0.5mL of tetanus toxoid should be given intramuscularly every 10 years to maintain immunity. Common side effects include redness, warmth, swelling and tenderness at the injection site, as well as general malaise, fever, pain, low blood pressure, nausea and joint pain. Special care must be taken when administering the injection to avoid entering a blood vessel. Tetanus toxoid is safe for breastfeeding mothers and their infants and does not affect immune response or breastfeeding. Its safety and effectiveness in infants under 6 weeks has not been established.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    You are on page 1of 1

     After the initial immunization series is completed, a booster dose of 0.

    5mL of tetanus toxoid


    should be given intramuscularly every 10 yrs to maintain adequate immunity.
    SIDE EFFECT/ ADVERSE REACTION:
    o Body System as a whole:
    Redness, warmth, edema, induration with or without tenderness as well as urticaria, and rash.
    Malaise, transient fever, pain, hypotension, nausea, and arthralgia
    NURSING CONSIDERATION:
     Shake well the vial before withdrawing each dose
     Special care should be taken to ensure that the injection does not enter the blood vessel
     For Nursing Mothers:
    Tetanus Toxoid does not affect the safety of mothers who are breastfeeding or their infants.
    Breastfeeding does not adversely affect immune response and is not a contraindication for
    vaccination
     For Pediatric Use:
    Safety and effectiveness of tetanus toxoid in infants below the age of 6 weeks has not been
    established. However, this vaccine is not indicated for children under 7 yrs of age.
     For Geriatric Use:
    Tetanus Toxoid should only be used in geriatric patients known to have received a primary series
    of tetanus-containing vaccine, since many such as persons have no prior immunity.

    You might also like